Guardant Health, Inc. (1GH)
MTA
Closed
Aug 24, 2026
Day's Range
140.2252 wk Range
42.00Overview - 1GH - Guardant Health, Inc.
Key Statistics
Valuation
Enterprise Value
16.66B
P/E (Trailing)
‪-42.23‬
PEG Ratio
‪-3.37‬
Price / Sales (TTM)
‪15.90‬
Price / Book
‪-83.59‬
EV / EBITDA
‪-45.19‬
Profitability
Gross Margin
‪65.38%‬
Profit Margin
‪-38.32%‬
Operating Margin
‪-38.24%‬
Return on Assets
‪-18.07%‬
Return on Equity
‪419.18%‬
Ownership
Shares Outstanding
133.61M
Float
129.39M
Held by Insiders
‪3.97%‬
Held by Institutions
‪100.91%‬
Price stats
Beta
‪1.58‬
50-Day Avg
‪135.33‬
200-Day Avg
‪99.60‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 1GH - Guardant Health, Inc.
Peers - 1GH - Guardant Health, Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on MTA.
Profile Summary - 1GH - Guardant Health, Inc.
About
Guardant Health Inc. is a precision oncology company that develops and provides blood and tissue-based tests, along with vast data sets and advanced analytics, to support cancer treatment, monitoring, and early detection. Its core offerings include the Guardant360 family of liquid biopsy tests, such as Guardant360 CDx…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
